Nanotechnology is one of the primary drivers of technology innovation, and it is one of the leading pillars of the six Key Enabling Technologies of Horizon 2020. Among the different application scopes of nanotechnology, its use in medicine has attracted considerable attention for its potential advances in healthcare, personalised medicine and to tackle complex issues such as the targeted and programmed delivery of drugs. The birth of nanomedicine required integration of different research field, such as nanoscience, physics, chemistry, modern pharmacy and clinical practice into a unique multidisciplinary research topic, all of which will be applied in the context of NanoCarb.
The overall aim of the NanoCarb ITN is to train a new generation of creative and innovative multidisciplinary early-stage researchers in the fields of nanotechnology and carbohydrate chemistry through an integrated research training programme in academia, industry and research centre environments. At the end of this project, the ESRs expertise will make them excellent candidates for a career in academia or industrial sectors.
NanoCarb benefits from the multidisciplinary expertise of 8 Beneficiaries and 10 Partner Organisations working from academic universities, Research Centres, SMEs and large BioPharma companies in the field of synthetic chemistry, polymer chemistry, biochemistry to explore new BioNano formulations. This innovative training programme will provide unique training to the 15 ESRs that will be hired within the project and will become new multidisciplinary leaders in nanomedicine. The success of this research proposal is built on such core multidisciplinary expertise working together for the same objectives.